1505 related articles for article (PubMed ID: 29462379)
1. A Cross-Talk Between Microbiota-Derived Short-Chain Fatty Acids and the Host Mucosal Immune System Regulates Intestinal Homeostasis and Inflammatory Bowel Disease.
Gonçalves P; Araújo JR; Di Santo JP
Inflamm Bowel Dis; 2018 Feb; 24(3):558-572. PubMed ID: 29462379
[TBL] [Abstract][Full Text] [Related]
2. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
3. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases.
Sun M; Wu W; Liu Z; Cong Y
J Gastroenterol; 2017 Jan; 52(1):1-8. PubMed ID: 27448578
[TBL] [Abstract][Full Text] [Related]
4. Intestinal microbiota in inflammatory bowel disease: friend of foe?
Fava F; Danese S
World J Gastroenterol; 2011 Feb; 17(5):557-66. PubMed ID: 21350704
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease.
Russo E; Giudici F; Fiorindi C; Ficari F; Scaringi S; Amedei A
Front Immunol; 2019; 10():2754. PubMed ID: 31824517
[TBL] [Abstract][Full Text] [Related]
6. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
7. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
8. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
9. Short chain fatty acids and its producing organisms: An overlooked therapy for IBD?
Deleu S; Machiels K; Raes J; Verbeke K; Vermeire S
EBioMedicine; 2021 Apr; 66():103293. PubMed ID: 33813134
[TBL] [Abstract][Full Text] [Related]
10. Regulatory role of short-chain fatty acids in inflammatory bowel disease.
Zhang Z; Zhang H; Chen T; Shi L; Wang D; Tang D
Cell Commun Signal; 2022 May; 20(1):64. PubMed ID: 35546404
[TBL] [Abstract][Full Text] [Related]
11. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
[TBL] [Abstract][Full Text] [Related]
12. An Insight Into the Intestinal Web of Mucosal Immunity, Microbiota, and Diet in Inflammation.
Yap YA; Mariño E
Front Immunol; 2018; 9():2617. PubMed ID: 30532751
[TBL] [Abstract][Full Text] [Related]
13. Short-chain fatty acids affect the development of inflammatory bowel disease through intestinal barrier, immunology, and microbiota: A promising therapy?
Peng K; Xia S; Xiao S; Yu Q
J Gastroenterol Hepatol; 2022 Sep; 37(9):1710-1718. PubMed ID: 35906780
[TBL] [Abstract][Full Text] [Related]
14. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
15. Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease.
Li G; Lin J; Zhang C; Gao H; Lu H; Gao X; Zhu R; Li Z; Li M; Liu Z
Gut Microbes; 2021; 13(1):1968257. PubMed ID: 34494943
[TBL] [Abstract][Full Text] [Related]
16. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
17. Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasis.
Yamada T; Hino S; Iijima H; Genda T; Aoki R; Nagata R; Han KH; Hirota M; Kinashi Y; Oguchi H; Suda W; Furusawa Y; Fujimura Y; Kunisawa J; Hattori M; Fukushima M; Morita T; Hase K
EBioMedicine; 2019 Oct; 48():513-525. PubMed ID: 31521614
[TBL] [Abstract][Full Text] [Related]
18. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
19. Enteroendocrine Cells: Sensing Gut Microbiota and Regulating Inflammatory Bowel Diseases.
Yu Y; Yang W; Li Y; Cong Y
Inflamm Bowel Dis; 2020 Jan; 26(1):11-20. PubMed ID: 31560044
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease.
Buela KA; Omenetti S; Pizarro TT
Curr Opin Gastroenterol; 2015 Nov; 31(6):449-55. PubMed ID: 26398682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
